Sanjivani Paranteral Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 328426, "name": "Sanjiv.Parant.", "stock_name": "Sanjiv.Parant.", "full_name": "Sanjivani Paranteral Ltd", "name_url": "stocks-analysis/sanjivparant", "exchange": 0, "exchangecode": "", "primexch": 0, "country_id": 34, "currency": "INR", "cmp": "163.30", "chg": -2.05, "chgp": "-1.24%", "dir": -1, "prev_price": "165.35", "mcapval": "209.00 Cr", "mcap": "Micro Cap", "scripcode": 531569, "symbol": "", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "India SENSEX", "isin": "INE860D01013", "curr_date": "May 08", "curr_time": "", "bse_nse_vol": "8.25 k", "exc_status": "Active", "traded_date": "May 08, 2026", "traded_date_str": "2026 05 08", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sanjivparant-328426-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "When is the next results date for Sanjivani Paranteral Ltd?", "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-sanjivani-paranteral-ltd-3978464", "imagepath": "", "date": "2026-05-06 23:16:06", "description": "The next results date for Sanjivani Paranteral Ltd is scheduled for 14 May 2026...." }, { "title": "Sanjivani Paranteral Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/sanjivani-paranteral-ltd-is-rated-sell-3972531", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SanjivaniParant_mojoScore_3972531.png", "date": "2026-05-02 10:10:38", "description": "Sanjivani Paranteral Ltd is rated Sell by MarketsMOJO. This rating was last updated on 20 Apr 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 02 May 2026, providing investors with the latest perspective on the company’s position in the market." }, { "title": "Sanjivani Paranteral Ltd Downgraded to Sell Amid Bearish Technicals and Market Underperformance", "link": "https://www.marketsmojo.com/news/stock-recommendation/sanjivani-paranteral-ltd-downgraded-to-sell-amid-bearish-technicals-and-market-underperformance-3955037", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/SanjivaniParant_mojoScore_3955037.png", "date": "2026-04-21 08:03:08", "description": "Sanjivani Paranteral Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 20 Apr 2026. This decision follows a comprehensive reassessment across four key parameters: Quality, Valuation, Financial Trend, and Technicals. Despite some positive long-term growth indicators, the stock’s recent performance and technical signals have raised concerns among analysts, prompting a cautious stance." }, { "title": "Sanjivani Paranteral Ltd Gains 6.20%: Technical Upgrade and Valuation Shift Drive Momentum", "link": "https://www.marketsmojo.com/news/stocks-in-action/sanjivani-paranteral-ltd-gains-620-technical-upgrade-and-valuation-shift-drive-momentum-3952794", "imagepath": "", "date": "2026-04-19 09:00:41", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>13 Apr:</strong> Stock opens at Rs.167.00, declines 1.45%</p>\n <p><strong>15 Apr:</strong> Sharp rally to Rs.181.40 (+8.62%) following rating upgrade</p>\n <p><strong>16 Apr:</strong> Valuation shifts to expensive amid strong price rally</p>\n <p><strong>17 Apr:</strong> Week closes at Rs.179.95, marginal decline of 0.14%</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.167.00</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.179...." }, { "title": "Sanjivani Paranteral Ltd Upgraded to Hold by MarketsMOJO on Technical Improvements", "link": "https://www.marketsmojo.com/news/stock-recommendation/sanjivani-paranteral-ltd-upgraded-to-hold-by-marketsmojo-on-technical-improvements-3948216", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/SanjivaniParant_mojoScore_3948216.png", "date": "2026-04-16 08:02:53", "description": "Sanjivani Paranteral Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Sell to Hold as of 15 Apr 2026. This shift reflects nuanced changes across four key parameters: quality, valuation, financial trend, and technicals. Despite a challenging year marked by underperformance relative to the broader market, the company’s improving fundamentals and technical indicators have prompted a reassessment of its outlook." }, { "title": "Sanjivani Paranteral Ltd Valuation Shifts Signal Changing Market Sentiment", "link": "https://www.marketsmojo.com/news/stocks-in-action/sanjivani-paranteral-ltd-valuation-shifts-signal-changing-market-sentiment-3947997", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/SanjivaniParant_valuationdot_3947997.png", "date": "2026-04-16 08:00:23", "description": "Sanjivani Paranteral Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an expensive rating amid a recent surge in its share price. This change reflects evolving market perceptions in the Pharmaceuticals & Biotechnology sector, with the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now exceeding historical and peer averages. Investors are weighing these valuation adjustments against the company’s financial performance and sector dynamics to reassess its attractiveness." }, { "title": "Sanjivani Paranteral Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/sanjivani-paranteral-ltd-is-rated-sell-3944501", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/SanjivaniParant_mojoScore_3944501.png", "date": "2026-04-13 10:10:45", "description": "Sanjivani Paranteral Ltd is rated Sell by MarketsMOJO, with this rating last updated on 01 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 April 2026, providing investors with the latest insights into the company’s performance and outlook." }, { "title": "Sanjivani Paranteral Ltd Gains 9.41%: 3 Key Factors Driving the Week’s Volatility", "link": "https://www.marketsmojo.com/news/stocks-in-action/sanjivani-paranteral-ltd-gains-941-3-key-factors-driving-the-weeks-volatility-3932402", "imagepath": "", "date": "2026-04-05 10:00:04", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>30 Mar:</strong> New 52-week low at Rs.132.75</p>\n <p><strong>1 Apr:</strong> Stock surges 16.65% to Rs.154.85 on upgrade</p>\n <p><strong>2 Apr:</strong> Downgrade to Sell amid mixed signals, stock closes at Rs.152.90</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.139.75</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.152.90</div><div class=\"stat-change positive\">+9.41%</div></div>\n <div class=\"stat-item\"><div class=\"stat-la..." }, { "title": "Sanjivani Paranteral Ltd Downgraded to Sell Amidst Mixed Financial Signals", "link": "https://www.marketsmojo.com/news/stock-recommendation/sanjivani-paranteral-ltd-downgraded-to-sell-amidst-mixed-financial-signals-3929564", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/SanjivaniParant_mojoScore_3929564.png", "date": "2026-04-02 08:01:35", "description": "Sanjivani Paranteral Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has been downgraded from a Hold to a Sell rating as of 1 April 2026. Despite demonstrating robust financial metrics and operational efficiency, the stock’s significant underperformance relative to the broader market and valuation concerns have prompted a reassessment of its investment appeal." } ], "total": 221, "sid": "328426", "stock_news_url": "https://www.marketsmojo.com/news/sanjivani-paranteral-328426" }, "announcements": [ { "caption": "Board Meeting Intimation for Approval Of Audited Standalone And Consolidated Financial Results Along With Audit Report For The Fourth Quarter And Financial Year Ended 31St March 2026", "datetime": "05-May-2026", "details": "Sanjivani Paranteral Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2026 inter alia to consider and approve 1. To approve Audited Standalone and Consolidated Financial Results along with Audit Report for the Fourth Quarter and Financial Year Ended 31st March 2026 pursuant to Regulation 33 of the Listing Obligation and Disclosure Requirement 2015; 2. Any other matter with the permission of Chair and with the consent of a majority of the Directors present in the Meeting including at least one Independent Director.", "source": "BSE" }, { "caption": "Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A", "datetime": "28-Apr-2026", "details": "<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Sanjivani Paranteral Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L24300MH1994PLC081752</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>0.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: RAVIKUMAR BOGAM <br/> Designation: COMPANY SECRETARY <br/> EmailId: INFO@SANJIVANI.CO.IN</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: PRITESH JAIN <br/> Designation: CHIEF FINANCIAL OFFICER <br/> EmailId: PRITESH.JAIN@SANJIVANI.CO.IN</div> </div> <div> <br/> Date: 28/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>", "source": "BSE" }, { "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018", "datetime": "07-Apr-2026", "details": "Certificate under Reg 74(5) of SEBI (DP) Reg 2018 for the Quarter and Year ended on 31.03.2026.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "", "data": [ { "title": "BOARD MEETING", "txt": "14 May 2026" } ] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Sanjivani Paranteral Ltd has declared <strong>5%</strong> dividend, ex-date: 19 Sep 25", "dt": "2025-09-19", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

13 Apr: Stock opens at Rs.167.00, declines 1.45%

15 Apr: Sharp rally to Rs.181.40 (+8.62%) following rating upgrade

16 Apr: Valuation shifts to expensive amid strong price rally

17 Apr: Week closes at Rs.179.95, marginal decline of 0.14%

Read full news article

Sanjivani Paranteral Ltd Upgraded to Hold by MarketsMOJO on Technical Improvements

2026-04-16 08:02:53

Sanjivani Paranteral Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Sell to Hold as of 15 Apr 2026. This shift reflects nuanced changes across four key parameters: quality, valuation, financial trend, and technicals. Despite a challenging year marked by underperformance relative to the broader market, the company’s improving fundamentals and technical indicators have prompted a reassessment of its outlook.

Read full news article

Sanjivani Paranteral Ltd Valuation Shifts Signal Changing Market Sentiment

2026-04-16 08:00:23

Sanjivani Paranteral Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an expensive rating amid a recent surge in its share price. This change reflects evolving market perceptions in the Pharmaceuticals & Biotechnology sector, with the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now exceeding historical and peer averages. Investors are weighing these valuation adjustments against the company’s financial performance and sector dynamics to reassess its attractiveness.

Read full news article

Sanjivani Paranteral Ltd is Rated Sell

2026-04-13 10:10:45

Sanjivani Paranteral Ltd is rated Sell by MarketsMOJO, with this rating last updated on 01 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 April 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Sanjivani Paranteral Ltd Gains 9.41%: 3 Key Factors Driving the Week’s Volatility

2026-04-05 10:00:04

Key Events This Week

30 Mar: New 52-week low at Rs.132.75

1 Apr: Stock surges 16.65% to Rs.154.85 on upgrade

2 Apr: Downgrade to Sell amid mixed signals, stock closes at Rs.152.90

Read full news article

Sanjivani Paranteral Ltd Downgraded to Sell Amidst Mixed Financial Signals

2026-04-02 08:01:35

Sanjivani Paranteral Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has been downgraded from a Hold to a Sell rating as of 1 April 2026. Despite demonstrating robust financial metrics and operational efficiency, the stock’s significant underperformance relative to the broader market and valuation concerns have prompted a reassessment of its investment appeal.

Read full news article

View All News

Sr. No.	Particulars	Details
1	Name of Company	Sanjivani Paranteral Ltd
2	CIN NO.	L24300MH1994PLC081752
3	Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)	0.00
4	Highest Credit Rating during the previous FY	NA
4a	Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)	Not Applicable
5	Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework	BSE